Signed in as:
filler@godaddy.com
In the News
Imiricor Announces Sales Agreement with MiRTLE Medical
September 27, 2021 – Minneapolis, United States – Imiricor Medical Systems, Inc. (Company or Imiricor) (ASX:IMR), the global leader in MRI-guided cardiac ablation products, is pleased to announce it has entered into a Sales Distribution Agreement with MiRTLE Medical, LLC (MiRTLE), maker of an MRI-compatible 12-lead ECG system.
MiRTLE MRI-COMPATIBLE 12 LEAD ECG Receives CE Mark
May 12, 2021 – North Andover, Massachusetts –
MiRTLE Medical LLC, a medical device company focused on patient monitoring and safety during an MRI, is pleased to announce that it has received CE mark certification for the Company’s MiRTLE MRI‐Compatible 12‐Lead Electrocardiograph.
MiRTLE Medical Receives ISO 13485 Certification
MiRTLE Medical LLC, a medical device company focused on patient monitoring and safety during an MRI, today announced that the Company has earned ISO 13485:2016 certification for its quality management system.
Imricor and MiRTLE Medical Announce Joint Development Agreement to Deliver 12-Lead ECG for Real-Time MRI-guided Cardiac Ablations
Minneapolis, MN – November 02, 2017 - Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MRTM EP Recorder/Stimulator System. This integration, along with Imricor’s MR compatible catheters, will allow physicians to perform complex cardiac ablations, such as for treating ventricular tachycardia and atrial fibrillation, under real-time MRI-guidance.
MiRTLE Medical, LLC
1600 Osgood Street, Suite 2017, North Andover, MA 01845
Copyright © 2024 MiRTLE Medical, LLC - All Rights Reserved.
